TY - JOUR
KW - Buprenorphine/therapeutic use
KW - Female
KW - Humans
KW - Longitudinal Studies
KW - Male
KW - Medication Adherence/psychology/statistics & numerical data
KW - Middle Aged
KW - Narcotic Antagonists/therapeutic use
KW - Opiate Substitution Treatment/methods/psychology
KW - Opioid-Related Disorders/complications/drug therapy/psychology
KW - Pain/complications/drug therapy/psychology
KW - Primary Health Care/statistics & numerical data
KW - Treatment Outcome
AU - A. D. Fox
AU - N. L. Sohler
AU - J. L. Starrels
AU - Y. Ning
AU - A. Giovanniello
AU - C. O. Cunningham
A1 - 
AB - Physical pain is common among individuals seeking treatment for opioid dependence. Pain may negatively impact addiction treatment. The authors prospectively studied opioid-dependent individuals initiating office-based buprenorphine treatment, comparing buprenorphine treatment outcomes (treatment retention and opioid use) among participants with and without pain (baseline pain or persistent pain). Among 82 participants, 60% reported baseline pain and 38% reported persistent pain. Overall, treatment retention was 56% and opioid use decreased from 89% to 26% over 6 months. In multivariable analyses, the authors found no association between pain and buprenorphine treatment outcomes. Opioid-dependent individuals with and without pain can achieve similar success with buprenorphine treatment.
BT - Substance abuse
C5 - Opioids & Substance Use
CP - 4
CY - United States
DO - 10.1080/08897077.2011.638734
IS - 4
JF - Substance abuse
N2 - Physical pain is common among individuals seeking treatment for opioid dependence. Pain may negatively impact addiction treatment. The authors prospectively studied opioid-dependent individuals initiating office-based buprenorphine treatment, comparing buprenorphine treatment outcomes (treatment retention and opioid use) among participants with and without pain (baseline pain or persistent pain). Among 82 participants, 60% reported baseline pain and 38% reported persistent pain. Overall, treatment retention was 56% and opioid use decreased from 89% to 26% over 6 months. In multivariable analyses, the authors found no association between pain and buprenorphine treatment outcomes. Opioid-dependent individuals with and without pain can achieve similar success with buprenorphine treatment.
PP - United States
PY - 2012
SN - 1547-0164; 0889-7077
SP - 361
EP - 365
EP - 
T1 - Pain is not associated with worse office-based buprenorphine treatment outcomes
T2 - Substance abuse
TI - Pain is not associated with worse office-based buprenorphine treatment outcomes
U1 - Opioids & Substance Use
U2 - 22989279
U3 - 10.1080/08897077.2011.638734
VL - 33
VO - 1547-0164; 0889-7077
Y1 - 2012
ER -